NCT04670653View on ClinicalTrials.gov

Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis

PHASE3WithdrawnINTERVENTIONAL

0

Timeline

Start Date

August 1, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

October 31, 2023

Conditions

Allergic Rhinitis

Interventions

DRUG

MAGNÓLIA NASAL GEL

Magnólia nasal gel spray

DRUG

MOMETASONE FUROATE

Mometasone furoate nasal spray

Sponsors

Lead Sponsor

All Listed Sponsors

lead

EMS

INDUSTRY

NCT04670653 - Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis | Biotech Hunter | Biotech Hunter